Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases — Amir Pelleg (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases
Shared by
Peter J Barnes
Imperial College London
Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases
Article
2016
en
Authors
AP
Amir Pelleg
ES
Edward S. Schulman
Peter J Barnes
Imperial College London
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Effects of Aerosolized Adenosine 5′-Triphosphate vs Adenosine 5′-Monophosphate on Dyspnea and Airway Caliber in Healthy Nonsmokers and Patients With Asthma
Özen K. Başoğlu
,
Amir Pelleg
,
Sarah Essilfie-Quaye
,
Caterina Brindicci
,
Peter J Barnes
,
Sergei A. Kharitonov
Article
2015
Effects of Aerosolized Adenosine 5′-Triphosphate in Smokers and Patients With COPD
Özen K. Başoğlu
,
Peter J Barnes
,
Sergei A. Kharitonov
,
Amir Pelleg
Article
2018
Adenosine 5’-triphosphate’s role in bradycardia and syncope associated with pulmonary embolism
Amir Pelleg
,
Edward S. Schulman
,
Peter J Barnes
Article
2008
Small airways: an important but neglected target in the treatment of obstructive airway diseases
Graham Sturton
,
C. G. A. Persson
,
Peter J Barnes
Article
1990
Convenient syntheses of cytidine 5'-triphosphate, guanosine 5'-triphosphate, and uridine 5'-triphosphate and their use in the preparation of UDP-glucose, UDP-glucuronic acid, and GDP-mannose
Ethan S. Simon
,
Sven Grabowski
,
George M M Whitesides
Discussion(0)
No comments yet. Be the first to comment.